EUVIMEDEUVIMED entdecken
Open Access

The Geographic Distribution of Dimorphic Mycoses in the United States for the Modern Era

Patrick B Mazi iD, John M Sahrmann, Margaret A Olsen, Ariella Coler-Reilly, Adriana M Rauseo, Matthew Pullen, Julio C Zuniga-Moya, William G Powderly, Andrej Spec

Clinical Infectious Diseases · 03.04.2023 · 76 (7) · 1295-1301

DOI: 10.1093/cid/ciac882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 11.11.2022. Verfasst von Patrick B Mazi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA. Hauptthemen laut MEDLINE: Blastomycosis, Coccidioidomycosis, Histoplasmosis, Mycoses. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, Washington University Institute of Clinical and Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The dimorphic mycoses (DMs) of the United States—Histoplasma, Coccidioides, and Blastomyces—commonly known as endemic mycoses of North America (in addition to Paracoccidioides) are increasingly being diagnosed outside their historical areas of endemicity. Despite this trend, the maps outlining their geographic distributions have not been updated in more than half a century using a large, nationwide database containing individual-patient–level data.

Methods

This was a retrospective analysis of >45 million Medicare fee-for-service beneficiaries from 1 January 2007 through 31 December 2016. Diagnoses of histoplasmosis, coccidioidomycosis, and blastomycosis were defined by International Classification of Diseases, Ninth/10th Revision, codes. The primary outcome was the incidence of histoplasmosis, coccidioidomycosis, and blastomycosis for each US county. Clinically meaningful thresholds for incidence were defined as 100 cases/100 000 person-years for histoplasmosis and coccidioidomycosis and 50 cases/100 000 person-years for blastomycosis.

Results

There were 79 749 histoplasmosis, 37 726 coccidioidomycosis, and 6109 blastomycosis diagnoses in unique persons from 2007–2016 across 3143 US counties. Considering all US states plus Washington, DC, 94% (48/51) had ≥1 county above the clinically relevant threshold for histoplasmosis, 69% (35/51) for coccidioidomycosis, and 78% (40/51) for blastomycosis.

Conclusions

Persons with histoplasmosis, coccidioidomycosis, and blastomycosis are diagnosed in significant numbers outside their historical geographic distributions established >50 years ago. Clinicians should consider DM diagnoses based on compatible clinical syndromes with less emphasis placed on patients' geographic exposure. Increased clinical suspicion leading to a subsequent increase in DM diagnostic testing would likely result in fewer missed diagnoses, fewer diagnostic delays, and improved patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BlastomycosisCoccidioidomycosisHistoplasmosisMycosesAgedHumansUnited StatesRetrospective StudiesMedicare

Stichwörter der Autor:innen

blastomycosiscoccidioidomycosisdimorphicendemic mycoseshistoplasmosis

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
  • Division of Bone and Mineral Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
  • Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Patrick B Mazi

Förderung

  • NIAMS NIH HHS
  • NCATS NIH HHS
  • Washington University Institute of Clinical and Translational Sciences
  • National Center for Advancing Translational Sciences
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Astellas Pharma US ISR

Zitieren

APA

Mazi, P. B., Sahrmann, J. M., Olsen, M. A., Coler-Reilly, A., Rauseo, A. M., Pullen, M., Zuniga-Moya, J. C., Powderly, W. G., & Spec, A. (2023). The Geographic Distribution of Dimorphic Mycoses in the United States for the Modern Era. Clinical Infectious Diseases, 76(7), 1295-1301. https://doi.org/10.1093/cid/ciac882

Vancouver

Mazi PB, Sahrmann JM, Olsen MA, Coler-Reilly A, Rauseo AM, Pullen M, et al. The Geographic Distribution of Dimorphic Mycoses in the United States for the Modern Era. Clinical Infectious Diseases. 2023;76(7):1295-1301. doi:10.1093/cid/ciac882

BibTeX
@article{Mazi2023,
  author = {Mazi, Patrick B and Sahrmann, John M and Olsen, Margaret A and Coler-Reilly, Ariella and Rauseo, Adriana M and Pullen, Matthew and Zuniga-Moya, Julio C and Powderly, William G and Spec, Andrej},
  title = {The Geographic Distribution of Dimorphic Mycoses in the United States for the Modern Era},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {7},
  pages = {1295--1301},
  doi = {10.1093/cid/ciac882}
}
Kostenlos starten →